Glen Harbor Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $15.9M | Buy |
93,742
+28,754
| +44% | +$4.87M | 0.33% | 65 |
|
|
2019
Q2 | $11.9M | Sell |
64,988
-5,698
| -8% | -$1.04M | 0.25% | 84 |
|
|
2019
Q1 | $13M | Buy |
70,686
+1,342
| +2% | +$247K | 0.28% | 83 |
|
|
2018
Q4 | $11.5M | Sell |
69,344
-2,904
| -4% | -$481K | 0.28% | 79 |
|
|
2018
Q3 | $13.9M | Sell |
72,248
-4,378
| -6% | -$844K | 0.28% | 87 |
|
|
2018
Q2 | $13M | Sell |
76,626
-682
| -0.9% | -$116K | 0.28% | 86 |
|
|
2018
Q1 | $12.6M | Buy |
77,308
+35,310
| +84% | +$5.75M | 0.29% | 77 |
|
|
2017
Q4 | $6.29M | Sell |
41,998
-1,166
| -3% | -$175K | 0.14% | 136 |
|
|
2017
Q3 | $6.56M | Sell |
43,164
-15,114
| -26% | -$2.3M | 0.16% | 130 |
|
|
2017
Q2 | $7.51M | Sell |
58,278
-2,420
| -4% | -$312K | 0.18% | 105 |
|
|
2017
Q1 | $6.64M | Sell |
60,698
-6,006
| -9% | -$657K | 0.17% | 115 |
|
|
2016
Q4 | $4.91M | Buy |
+66,704
| New | +$4.91M | 0.13% | 138 |
|